Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	CACNA1B CACNA1E DCHS2 PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TENM2 SVEP1 ITPR1 EFCAB9 FAT2 PCDH15	9.67e-06	749	175	20	GO:0005509
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 PCDHA9 NRCAM PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2 PCDH15 NECTIN4	4.35e-12	187	172	16	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 PCDHA9 NRCAM PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TENM2 FAT2 ARVCF PCDH15 NECTIN4 TNFAIP3	1.73e-11	313	172	19	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	DCHS2 PCDHA9 ANK3 NRCAM PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PTPN22 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TENM2 SVEP1 FAT2 ARVCF BTN1A1 CD44 PCDH15 NECTIN4 TNFAIP3 NCK2	3.37e-06	1077	172	25	GO:0098609
Domain	Cadherin_tail	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.46e-14	37	175	11	PF15974
Domain	Cadherin_CBD	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.46e-14	37	175	11	IPR031904
Domain	Cadherin_CS	DCHS2 PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2 PCDH15	1.76e-12	109	175	14	IPR020894
Domain	CADHERIN_1	DCHS2 PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2 PCDH15	2.92e-12	113	175	14	PS00232
Domain	Cadherin	DCHS2 PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2 PCDH15	2.92e-12	113	175	14	PF00028
Domain	CADHERIN_2	DCHS2 PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2 PCDH15	3.30e-12	114	175	14	PS50268
Domain	-	DCHS2 PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2 PCDH15	3.30e-12	114	175	14	2.60.40.60
Domain	CA	DCHS2 PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2 PCDH15	3.72e-12	115	175	14	SM00112
Domain	Cadherin-like	DCHS2 PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2 PCDH15	4.20e-12	116	175	14	IPR015919
Domain	Cadherin	DCHS2 PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2 PCDH15	5.33e-12	118	175	14	IPR002126
Domain	Cadherin_2	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.06e-11	65	175	11	PF08266
Domain	Cadherin_N	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.06e-11	65	175	11	IPR013164
Domain	KRAB	ZNF823 ZNF765 ZNF527 ZNF266 ZNF560 ZNF674 ZNF251 ZNF546 ZNF19 ZNF334 ZNF611 ZNF808 ZNF480 ZNF528 ZNF468	1.47e-06	358	175	15	PS50805
Domain	KRAB	ZNF823 ZNF765 ZNF527 ZNF266 ZNF560 ZNF674 ZNF251 ZNF546 ZNF19 ZNF334 ZNF611 ZNF808 ZNF480 ZNF528 ZNF468	2.14e-06	369	175	15	SM00349
Domain	KRAB	ZNF823 ZNF765 ZNF527 ZNF266 ZNF560 ZNF674 ZNF251 ZNF546 ZNF19 ZNF334 ZNF611 ZNF808 ZNF480 ZNF528 ZNF468	2.21e-06	370	175	15	IPR001909
Domain	KRAB	ZNF823 ZNF765 ZNF527 ZNF560 ZNF674 ZNF251 ZNF546 ZNF19 ZNF334 ZNF611 ZNF808 ZNF480 ZNF528 ZNF468	7.36e-06	358	175	14	PF01352
Domain	zf-C2H2_6	ZNF823 ZNF765 ZNF527 ZNF266 ZNF560 ZNF251 ZNF546 ZNF334 OSR1 ZNF611 ZNF808 ZNF480 ZNF468	8.59e-06	314	175	13	PF13912
Domain	Kinesin-like_KIF1-typ	KIF13B KIF1A	5.17e-04	4	175	2	IPR022140
Domain	KIF1B	KIF13B KIF1A	5.17e-04	4	175	2	PF12423
Domain	-	ZNF823 ZNF765 ZNF527 ZNF266 ZNF560 ZNF674 ZNF251 ZNF546 ZNF19 ZNF334 OSR1 ZNF611 ZNF808 ZNF480 ZNF528 ZNF468	6.69e-04	679	175	16	3.30.160.60
Domain	Myosin-like_IQ_dom	MYH1 MYH7 ASPM	7.02e-04	19	175	3	IPR027401
Domain	-	MYH1 MYH7 ASPM	7.02e-04	19	175	3	4.10.270.10
Domain	zf-C2H2	ZNF823 ZNF765 ZNF527 ZNF266 ZNF560 ZNF674 ZNF251 ZNF546 ZNF19 ZNF334 OSR1 ZNF611 ZNF808 ZNF480 ZNF528 ZNF468	8.31e-04	693	175	16	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF823 ZNF765 ZNF527 ZNF266 ZNF560 ZNF674 ZNF251 ZNF546 ZNF19 ZNF334 OSR1 ZNF611 ZNF808 ZNF480 ZNF528 ZNF468	8.43e-04	694	175	16	IPR013087
Domain	NA-bd_OB-fold	NAB1 MEIOB KARS1 BRCA2 RPA4	1.10e-03	83	175	5	IPR012340
Domain	Peptidase_M14	CPXM2 AGBL3 AGBL4	1.25e-03	23	175	3	PF00246
Domain	Peptidase_M14	CPXM2 AGBL3 AGBL4	1.25e-03	23	175	3	IPR000834
Domain	Kinesin_assoc	KIF13B KIF1A	1.28e-03	6	175	2	PF16183
Domain	Kinesin-like	KIF13B KIF1A	1.28e-03	6	175	2	IPR022164
Domain	Kinesin_assoc	KIF13B KIF1A	1.28e-03	6	175	2	IPR032405
Domain	DUF3694	KIF13B KIF1A	1.28e-03	6	175	2	PF12473
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	5.80e-23	15	177	11	15640798
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	5.22e-22	17	177	11	29911975
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.34e-21	18	177	11	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.34e-21	18	177	11	10662547
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.02e-19	24	177	11	24698270
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	8.62e-19	28	177	11	15347688
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4	6.25e-17	11	177	8	9655502
Pubmed	The DNA sequence and comparative analysis of human chromosome 5.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TENM2 EFCAB9	9.46e-17	75	177	13	15372022
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2	2.44e-15	72	177	12	10380929
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2	5.71e-15	77	177	12	10835267
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	6.53e-15	57	177	11	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	8.02e-15	58	177	11	30377227
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAT2	9.23e-15	80	177	12	10716726
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	5.17e-14	68	177	11	11230163
Pubmed	Proteins of the CNR family are multiple receptors for Reelin.	PCDHA9 PCDHA13 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4	6.08e-14	12	177	7	10612399
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.37e-13	74	177	11	10817752
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	TNPO1 DOCK3 PCDHA9 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA3 PCDHA2 PCDHA1 PANX2 TLR9 CSMD2 SHANK3 BRCA1 BRCA2	1.37e-12	329	177	17	17474147
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.84e-11	119	177	11	28625976
Pubmed	Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	5.05e-09	193	177	11	22589738
Pubmed	Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.	BRCA1 BRCA2 CDK4	5.16e-07	4	177	3	20842456
Pubmed	Common deletion variants causing protocadherin-α deficiency contribute to the complex genetics of BAV and left-sided congenital heart disease.	PCDHA9 PCDHA12 PCDHA7	1.29e-06	5	177	3	34888534
Pubmed	HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.	TNPO1 USP34 EPRS1 GPX8 POLR2A PSMC6 SSRP1 TMEM106B KARS1 CSNK2A2 PCCB ANAPC5 CDK4	8.12e-06	571	177	13	37167062
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DOCK3 USP34 EPRS1 DCHS2 SETMAR ANK3 NRCAM TTC28 KIF1A ADAMTS1 PARVB ZNF251 ADD3 ZNF334 CIAO3 DENND6B ZNF528 MERTK PCCB SPATC1L	9.70e-06	1285	177	20	35914814
Pubmed	The UAS thioredoxin-like domain of UBXN7 regulates E3 ubiquitin ligase activity of RNF111/Arkadia.	TNPO1 MICAL1 PSMC6 CSNK2A2 ANAPC5 CDK4	1.43e-05	102	177	6	37024974
Pubmed	Fine genetic and comparative mapping of the deafness mutation Ames waltzer on mouse chromosome 10.	ANK3 PCDH15 MMP11	2.08e-05	11	177	3	9653653
Pubmed	Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction.	ADAMTS1 CD44 ADAMTS15 SEMA3E	2.09e-05	32	177	4	31434798
Pubmed	Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.	BRCA1 BRCA2	2.58e-05	2	177	2	29480828
Pubmed	A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.	BRCA1 BRCA2	2.58e-05	2	177	2	17924331
Pubmed	Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.	BRCA1 BRCA2	2.58e-05	2	177	2	12833555
Pubmed	Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.	BRCA1 BRCA2	2.58e-05	2	177	2	14735173
Pubmed	Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	2.58e-05	2	177	2	16032702
Pubmed	Oral contraceptive use and BRCA penetrance: a case-only study.	BRCA1 BRCA2	2.58e-05	2	177	2	19549808
Pubmed	Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.	BRCA1 BRCA2	2.58e-05	2	177	2	34101484
Pubmed	Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.	BRCA1 BRCA2	2.58e-05	2	177	2	26961146
Pubmed	Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study.	BRCA1 BRCA2	2.58e-05	2	177	2	20512419
Pubmed	Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus.	BRCA1 BRCA2	2.58e-05	2	177	2	37804357
Pubmed	Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.	BRCA1 BRCA2	2.58e-05	2	177	2	22053997
Pubmed	BRCA mutations in women with inflammatory breast cancer.	BRCA1 BRCA2	2.58e-05	2	177	2	29044548
Pubmed	Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy.	BRCA1 BRCA2	2.58e-05	2	177	2	33834176
Pubmed	Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring.	BRCA1 BRCA2	2.58e-05	2	177	2	18200524
Pubmed	Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.	BRCA1 BRCA2	2.58e-05	2	177	2	29298688
Pubmed	Fertility in women with BRCA mutations: a case-control study.	BRCA1 BRCA2	2.58e-05	2	177	2	19200971
Pubmed	Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.	BRCA1 BRCA2	2.58e-05	2	177	2	16030099
Pubmed	Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.	BRCA1 BRCA2	2.58e-05	2	177	2	28212807
Pubmed	Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer.	BRCA1 BRCA2	2.58e-05	2	177	2	11448436
Pubmed	Rapid evolution of BRCA1 and BRCA2 in humans and other primates.	BRCA1 BRCA2	2.58e-05	2	177	2	25011685
Pubmed	Breast magnetic resonance imaging for screening high-risk women.	BRCA1 BRCA2	2.58e-05	2	177	2	23928241
Pubmed	Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.	BRCA1 BRCA2	2.58e-05	2	177	2	35980168
Pubmed	Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.	BRCA1 BRCA2	2.58e-05	2	177	2	11377596
Pubmed	BRCA mutations and risk of prostate cancer in Ashkenazi Jews.	BRCA1 BRCA2	2.58e-05	2	177	2	15131025
Pubmed	Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population.	BRCA1 BRCA2	2.58e-05	2	177	2	20033483
Pubmed	Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women.	CETP APOB	2.58e-05	2	177	2	20082485
Pubmed	Health survey and assessment of the polymorphisms BRCA1/P871L, BRCA1/Q356R, and BRCA2/N372H in female gas station workers in Rio de Janeiro.	BRCA1 BRCA2	2.58e-05	2	177	2	28862356
Pubmed	BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.	BRCA1 BRCA2	2.58e-05	2	177	2	22425665
Pubmed	BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.	BRCA1 BRCA2	2.58e-05	2	177	2	18752448
Pubmed	Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.	BRCA1 BRCA2	2.58e-05	2	177	2	22425664
Pubmed	Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.	BRCA1 BRCA2	2.58e-05	2	177	2	22970155
Pubmed	Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.	BRCA1 BRCA2	2.58e-05	2	177	2	34304065
Pubmed	Absence of 185delAG and 6174delT Mutations among Breast Cancer Patients of Eastern India.	BRCA1 BRCA2	2.58e-05	2	177	2	26625823
Pubmed	Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.	BRCA1 BRCA2	2.58e-05	2	177	2	26852015
Pubmed	Meta-analysis of BRCA1 and BRCA2 penetrance.	BRCA1 BRCA2	2.58e-05	2	177	2	17416853
Pubmed	Power spectral analysis of mammographic parenchymal patterns for breast cancer risk assessment.	BRCA1 BRCA2	2.58e-05	2	177	2	18175183
Pubmed	Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients.	BRCA1 BRCA2	2.58e-05	2	177	2	38057686
Pubmed	Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.	BRCA1 BRCA2	2.58e-05	2	177	2	27914478
Pubmed	BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations.	BRCA1 BRCA2	2.58e-05	2	177	2	16455195
Pubmed	The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.	BRCA1 BRCA2	2.58e-05	2	177	2	23810788
Pubmed	Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.	BRCA1 BRCA2	2.58e-05	2	177	2	29727326
Pubmed	Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.	BRCA1 BRCA2	2.58e-05	2	177	2	35871032
Pubmed	Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.	BRCA1 BRCA2	2.58e-05	2	177	2	22739995
Pubmed	The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.	BRCA1 BRCA2	2.58e-05	2	177	2	27794048
Pubmed	Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.	BRCA1 BRCA2	2.58e-05	2	177	2	20972632
Pubmed	BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.	BRCA1 BRCA2	2.58e-05	2	177	2	19499246
Pubmed	Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.	BRCA1 BRCA2	2.58e-05	2	177	2	19656164
Pubmed	Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.	BRCA1 BRCA2	2.58e-05	2	177	2	15986445
Pubmed	Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.	BRCA1 BRCA2	2.58e-05	2	177	2	18165636
Pubmed	Large genomic rearrangements in BRCA1 and BRCA2: implications for patient care.	BRCA1 BRCA2	2.58e-05	2	177	2	23615136
Pubmed	Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women.	BRCA1 BRCA2	2.58e-05	2	177	2	29982601
Pubmed	Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	2.58e-05	2	177	2	28343309
Pubmed	BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.	BRCA1 BRCA2	2.58e-05	2	177	2	17925560
Pubmed	Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer.	BRCA1 BRCA2	2.58e-05	2	177	2	27601588
Pubmed	Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	2.58e-05	2	177	2	23918944
Pubmed	Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.	BRCA1 BRCA2	2.58e-05	2	177	2	33558422
Pubmed	Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.	BRCA1 BRCA2	2.58e-05	2	177	2	30430339
Pubmed	Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.	BRCA1 BRCA2	2.58e-05	2	177	2	33534430
Pubmed	BRCA 1, 2 mutation and earlier menopause: could BRCA 1,2 be used as predictor of menopause?	BRCA1 BRCA2	2.58e-05	2	177	2	34137566
Pubmed	BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing.	BRCA1 BRCA2	2.58e-05	2	177	2	33918338
Pubmed	Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.	BRCA1 BRCA2	2.58e-05	2	177	2	26181175
Pubmed	Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations.	BRCA1 BRCA2	2.58e-05	2	177	2	14517958
Pubmed	Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.	BRCA1 BRCA2	2.58e-05	2	177	2	18559571
Pubmed	BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.	BRCA1 BRCA2	2.58e-05	2	177	2	27225819
Pubmed	BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.	BRCA1 BRCA2	2.58e-05	2	177	2	18559594
Pubmed	Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing.	BRCA1 BRCA2	2.58e-05	2	177	2	31131559
Pubmed	The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.	BRCA1 BRCA2	2.58e-05	2	177	2	11981002
Pubmed	Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.	BRCA1 BRCA2	2.58e-05	2	177	2	29020660
Pubmed	An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.	BRCA1 BRCA2	2.58e-05	2	177	2	21934105
Pubmed	Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies.	BRCA1 BRCA2	2.58e-05	2	177	2	28199346
Pubmed	Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance.	CACNA1B CACNA1E	2.58e-05	2	177	2	15610184
Pubmed	Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.	BRCA1 BRCA2	2.58e-05	2	177	2	18092194
Pubmed	Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.	BRCA1 BRCA2	2.58e-05	2	177	2	16541324
Pubmed	Investigating the relationship between BRCA1 and BRCA2 genes methylation profile and sperm DNA fragmentation in infertile men.	BRCA1 BRCA2	2.58e-05	2	177	2	31095775
Interaction	PCDHA10 interactions	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2	9.89e-16	22	173	10	int:PCDHA10
Interaction	PCDHA8 interactions	PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1	9.31e-10	55	173	9	int:PCDHA8
Interaction	PCDHA7 interactions	PCDHA9 PCDHA12 PCDHA8 PCDHA7 PCDHA4 PCDHA2	1.04e-09	14	173	6	int:PCDHA7
Interaction	FLT3 interactions	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 APOB PCDHA1 KARS1 BRCA1 BRCA2	1.09e-07	318	173	15	int:FLT3
Interaction	PCDHA11 interactions	PCDHA9 PCDHA12 PCDHA4 PCDHA3 PCDHA1	4.64e-07	19	173	5	int:PCDHA11
Interaction	PCDHA1 interactions	PCDHA8 PCDHA4 PCDHA3 PCDHA1	6.39e-07	9	173	4	int:PCDHA1
Interaction	ABCB9 interactions	PCDHA8 PCDHA3 TLR9 LRRC8B DDX60L	1.00e-05	34	173	5	int:ABCB9
Interaction	PCDHA3 interactions	PCDHA9 PCDHA8 PCDHA6 PCDHA3 PCDHA1	1.00e-05	34	173	5	int:PCDHA3
Interaction	ERCC5 interactions	EPRS1 POLR2A BRCA1 BRCA2 CSNK2A2 RPA4	1.25e-05	60	173	6	int:ERCC5
Interaction	PCDHA4 interactions	PCDHA9 PCDHA12 PCDHA8 PCDHA7 PCDHA4 PCDHA1	1.25e-05	60	173	6	int:PCDHA4
Interaction	PCDHGA10 interactions	PCDHA9 PCDHA12 PCDHA8 PCDHA4	1.84e-05	19	173	4	int:PCDHGA10
Interaction	PCDHA6 interactions	PCDHA8 PCDHA6 PCDHA3	5.03e-05	9	173	3	int:PCDHA6
Cytoband	5q31	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.03e-12	115	177	11	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	2.69e-08	298	177	11	chr5q31
Cytoband	19q13.41	ZNF611 ZNF888 ZNF808 ZNF480 ZNF468	1.35e-05	78	177	5	19q13.41
Cytoband	22q13.33	PANX2 MAPK12 MOV10L1 DENND6B	1.42e-05	38	177	4	22q13.33
Cytoband	3p26.1	SETMAR ITPR1	9.51e-04	12	177	2	3p26.1
GeneFamily	Clustered protocadherins	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	5.03e-13	64	123	11	20
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF823 ZNF765 ZNF527 ZNF266 ZNF560 ZNF674 ZNF251 ZNF546 ZNF19 ZNF334 OSR1 ZNF611 ZNF888 ZNF808 ZNF480 ZNF528 ZNF468	7.33e-06	718	123	17	28
GeneFamily	Cadherin related	DCHS2 FAT2 PCDH15	1.95e-04	17	123	3	24
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.66e-06	261	176	11	MM1277
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	PCDHA9 PCDHA13 PCDHA12 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	5.13e-06	238	176	10	M2020
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305	ZNF823 USP34 EPRS1 MYH7 ZNF560 NHLRC2 SIM1 USP31 AP4E1 SOCS4 ASPM	1.36e-05	266	175	11	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	DOCK3 SLC9A9 MYH7 LAIR1 OBSCN TENM2 XIRP2 DDX60L MERTK	2.82e-08	170	177	9	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 CPXM2 GRB14 SIM1 ITPR1 KCNJ1 CERS3 FRMD3	4.76e-07	173	177	8	0c74bdb40e635d906fd180412c23bf7fed61621e
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	MYH7 ANK3 OBSCN LAMA2 TENM2 XIRP2 DDX60L GAREM1	9.66e-07	190	177	8	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF823 GRB14 PCDHA3 ARVCF TRIM16L MMP11 BBOX1 PCYT1B	1.27e-06	197	177	8	fd76cc5e12c7e7943a48f739e4f0626ff7211f51
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PCDHA7 PCDHA5 PARVB SHANK3 CERS3 LRRC8B FGD5	1.50e-06	140	177	7	b9aeb7dda7f377b580dd8a44912f300721437387
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZCWPW1 ADAMTS1 ZNF546 AAR2 ITPR1 MAPK12 WDCP	3.21e-06	157	177	7	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 HKDC1 TENM2 NDST3 MOV10L1 CFAP57 GAREM1	3.35e-06	158	177	7	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 HKDC1 TENM2 NDST3 MOV10L1 CFAP57 GAREM1	3.35e-06	158	177	7	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ADAMTS1 PCDHA8 PCDHA7 PCDHA3 SVEP1 MERTK DMPK	4.11e-06	163	177	7	f1ec2625b52664308968b01d8e0275e1e0751480
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST10 GEMIN5 PCDHA8 TBC1D25 RO60 AP4E1 NECTIN4	4.11e-06	163	177	7	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1B CACNA1E CPXM2 KIF1A CSMD2 AGBL4 SLC29A4	5.22e-06	169	177	7	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E ARHGAP32 NET1 LAIR1 OBSCN ITPR1 SULT6B1	6.81e-06	176	177	7	74f851a398c7562dd713bc0d8d488c0037243112
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK3 MYH7 OBSCN LAMA2 TENM2 XIRP2 DDX60L	6.81e-06	176	177	7	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	facs-Marrow-T_cells-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E ARHGAP32 NET1 LAIR1 OBSCN ITPR1 SULT6B1	6.81e-06	176	177	7	31b5459a978d5cdde0af03a77401e0464d8c95ba
ToppCell	facs-Pancreas-Endocrine-24m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 CPXM2 GPX8 PARP3 MEIOB SVEP1 OSR1	7.61e-06	179	177	7	6f51a4580c06fc55cc764052c9b26f7c55660282
ToppCell	facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 CPXM2 GPX8 PARP3 MEIOB SVEP1 OSR1	7.61e-06	179	177	7	f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23
ToppCell	facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 CPXM2 GPX8 PARP3 MEIOB SVEP1 OSR1	7.61e-06	179	177	7	a6ce1fa338d4905bd6afef00763ac83e916a0b37
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	DOCK3 MYH7 ANK3 OBSCN TENM2 XIRP2 DDX60L	8.48e-06	182	177	7	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 NRCAM OBSCN APOB PKHD1L1 XIRP2 PCDH15	9.10e-06	184	177	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 NRCAM OBSCN APOB PKHD1L1 XIRP2 PCDH15	9.10e-06	184	177	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 NRCAM OBSCN APOB PKHD1L1 XIRP2 PCDH15	9.10e-06	184	177	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PCDHA9 NRCAM OBSCN LAMA2 PCDHA5 PCDHA3 NCK2	9.77e-06	186	177	7	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	COVID-19-kidney-DCT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CPXM2 HKDC1 GRB14 SIM1 AGBL4 KCNJ1 GAREM1	1.05e-05	188	177	7	1d56cd409793f05cca20757ab26e91f1a1ee67b5
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZCWPW1 ANK3 KIF1A MAGEB16 SIM1 NDST3 FRMD3	1.05e-05	188	177	7	502045a39ffb1e92bd9499848368e8fa971edb88
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRB14 NHLRC2 SH3TC1 LRRC8B MERTK CA4 DYRK2	1.08e-05	189	177	7	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK3 ANK3 NRCAM GRB14 NECTIN4 FRMD3 SEMA3E	1.08e-05	189	177	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	droplet-Marrow-nan-3m-Hematologic-erythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST10 ATAD5 PKHD1L1 BRCA1 BRCA2 ASPM PCYT1B	1.08e-05	189	177	7	8a38baee58a27c2fa3f4bd131ab9f15723ed9295
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RBM15 AMPD3 NET1 BRCA2 SOCS4 ASPM RUBCN	1.12e-05	190	177	7	3f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPD3 STON1 GRB14 NHLRC2 ADD3 MERTK CA4	1.16e-05	191	177	7	df8cdbc26443e55a203cbafa21b0952a2a55b9bf
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCDC71L AMPD3 OTUD1 BCAT1 CD44 DDX60L TNFAIP3	1.16e-05	191	177	7	0b296404ebad0aadb75737f8c0462ec6934fc8bb
ToppCell	COVID-19-kidney-TAL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HKDC1 GRB14 SIM1 AGBL4 SYT16 KCNJ1 BBOX1	1.16e-05	191	177	7	fe55475ce0666ab5122447a813dc2369e24947b8
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RBM15 AMPD3 NET1 BRCA2 SOCS4 ASPM RUBCN	1.20e-05	192	177	7	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	CPXM2 ADAMTS1 PKHD1L1 SHANK3 PCDH15 PRKCH FGD5	1.28e-05	194	177	7	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	DOCK3 MYH7 ANK3 OBSCN LAMA2 TENM2 XIRP2	1.33e-05	195	177	7	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 CPXM2 GRB14 SIM1 ITPR1 KCNJ1 FRMD3	1.33e-05	195	177	7	a38d9dc6192aea673d96fda6b25e81223fda3abf
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1B ARHGAP32 NRCAM TENM2 ITPR1 AGBL4 SYT16	1.46e-05	198	177	7	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	STON1 LAMA2 PCDHA12 NHLRC2 SPRYD3 DENND6B GAREM1	1.56e-05	200	177	7	5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-Mesoderm\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	STON1 APOB XIRP2 PRKCH	1.71e-05	39	177	4	3479d255b87fa8042c51d80a3eb81a774850132e
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY10 DOCK3 CACNA1B SIM1 MOV10L1 PCDH15	2.52e-05	145	177	6	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	LAMA2 GRB14 AGBL3 OSR1 DDX60L RPA4	3.16e-05	151	177	6	4533bccc996395f74b16af939ce79b6fe253c073
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	LAMA2 GRB14 AGBL3 OSR1 DDX60L RPA4	3.16e-05	151	177	6	edb2f59789c295838d2030b80c792cbea25eaa3d
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Matrix_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	NAB1 MAGEB16 MYRFL SHANK3 CIAO3 FGD5	3.53e-05	154	177	6	928f49839b046b90c2f942458f3e365ddc4e0bc9
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADCY10 DOCK3 CACNA1B SIM1 PKHD1L1 PCDH15	4.69e-05	162	177	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPXM2 OTUD1 GRB14 PCDHA5 ITPR1 KCNJ1	4.69e-05	162	177	6	36ddebe3bb172c992739353b7b049b2dde98b559
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____NK_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MICAL1 ZCWPW1 APAF1 PRKCH TNFAIP3 DYRK2	4.69e-05	162	177	6	04a96442e0fcdb6a65b9e45044021677f9f53d38
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-NK_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MICAL1 ZCWPW1 APAF1 PRKCH TNFAIP3 DYRK2	4.69e-05	162	177	6	7adb3e279526e1f21033c10af0a0058258f21842
ToppCell	367C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZNF765 ZNF527 GPX8 LAMA2 GEMIN5 BCAT1	5.02e-05	164	177	6	1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF13B ATAD5 LAIR1 NECTIN4 RUBCN DYRK2	5.55e-05	167	177	6	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK3 MYH7 OBSCN LAMA2 TENM2 XIRP2	6.13e-05	170	177	6	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TENM2 SHANK3 EFCAB9 MAPK12 SH3TC1 FGD5	6.33e-05	171	177	6	b3e6e31dfe3623b960ccf692fdbd236fa4039923
ToppCell	droplet-Heart-4Chambers-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHA12 PARVB SHANK3 SH3TC1 PRKCH FGD5	6.75e-05	173	177	6	9a04271c51fae34f547db3206f9ff5857686e45c
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NRCAM GRB14 CSMD2 TENT5B NDST3 OSR1	6.97e-05	174	177	6	b7f5492ce8098f7eb0aef30ee558d00738d59d0e
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NRCAM GRB14 CSMD2 TENT5B NDST3 OSR1	6.97e-05	174	177	6	71730503be3d9c839c4c9e950145e2101d682a1c
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	NRCAM GRB14 CSMD2 TENT5B NDST3 OSR1	6.97e-05	174	177	6	ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NRCAM GRB14 CSMD2 TENT5B NDST3 OSR1	6.97e-05	174	177	6	cafe4d6b5f08d8888e9db6e196c66df991c03e7b
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	MYRFL SVEP1 ADD3 FGD5 CDK4 DYRK2	7.19e-05	175	177	6	2eca4c168dea2017ea0e383006e28abed22f32ec
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPXM2 NET1 OBSCN TENM2 DMPK SBK2	7.66e-05	177	177	6	c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPXM2 NET1 OBSCN TENM2 DMPK SBK2	7.66e-05	177	177	6	7ebdcedfe02da6d05bba3d625d8bd4c4ea96e4ad
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ATAD5 CSMD2 AGBL4 BRCA1 BRCA2 ASPM	8.40e-05	180	177	6	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	Pericytes-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DCHS2 NRCAM PCDHA6 FAM135B HEPH MMP11	8.66e-05	181	177	6	35c470988a93381eefa300831aabb813fa1b90bd
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK3 MYH7 OBSCN LAMA2 TENM2 XIRP2	8.66e-05	181	177	6	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HEPH TENT5B SYT16 CD44 DMPK SEMA3E	8.66e-05	181	177	6	beb2771820956be8b190c0088ae3c4efdb53c897
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	DOCK3 CACNA1B NRCAM KIF1A AGBL4 SLC29A4	8.93e-05	182	177	6	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KIF13B GPX8 KCNJ1 BBOX1 CA4 GAREM1	8.93e-05	182	177	6	a8cc56f32efe180e8fb5d69dbe606a794b3db700
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPXM2 GRB14 SIM1 ITPR1 KCNJ1 FRMD3	9.20e-05	183	177	6	2f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	ADCY10 CACNA1B NRCAM TENM2 FAT2 PCYT1B	9.48e-05	184	177	6	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	MYH7 ANK3 OBSCN LAMA2 TENM2 XIRP2	9.48e-05	184	177	6	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Serpinb1a_(Serpinb1a)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	APOB PCDHA1 TLR9 FAT2	9.51e-05	60	177	4	48adafeec1810bce5f118fa63d4a8ee7ab9ca0f7
ToppCell	Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Serpinb1a_(Serpinb1a)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	APOB PCDHA1 TLR9 FAT2	9.51e-05	60	177	4	a83afb89dbfc2e1cdfce57320d89c980bd8fb820
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS1 LAMA2 CSMD2 SVEP1 OSR1 ADAMTS15	9.76e-05	185	177	6	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK3 MYH7 OBSCN LAMA2 TENM2 XIRP2	9.76e-05	185	177	6	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF1A GRB14 BCAT1 MYRFL TSC22D4 FRMD3	9.76e-05	185	177	6	11c147f3f5570c4761d2bcff3bad28146b4a5861
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK3 CACNA1B CACNA1E NRCAM KIF1A FAM135B	9.76e-05	185	177	6	110d5f02759c8235b14aea524ea47199696094ea
ToppCell	droplet-Pancreas-Endocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPX8 PARVB MAPK12 PRKCH FGD5 CA4	9.76e-05	185	177	6	512a195ebbae445afe3722a3943020080daf2f3c
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP32 GPX8 SHANK3 ARVCF PRKCH FGD5	1.01e-04	186	177	6	2cae34336f184f971f7c8684cc27c23a4e7369ed
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP32 GPX8 SHANK3 ARVCF PRKCH FGD5	1.01e-04	186	177	6	90d53c2597a9f3a2b39afba75adfc54f1ca0a4db
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CPXM2 ADAMTS1 GPX8 LAMA2 SVEP1 OSR1	1.01e-04	186	177	6	07d94d5d1c2fe7bb909a07ca81058a0eabc65c60
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	STON1 NRCAM CPXM2 GPX8 SVEP1 BBOX1	1.04e-04	187	177	6	f1d0fc625e0e7881b3f290742fd7148d995eb71e
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	STON1 NRCAM CPXM2 GPX8 SVEP1 BBOX1	1.04e-04	187	177	6	02e7246ef5ad41773d14426254e139b156d45c1d
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	CPXM2 PKHD1L1 SHANK3 PCDH15 PRKCH FGD5	1.04e-04	187	177	6	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZNF527 TTC28 NAB1 ORC5 SH3TC1 SOCS4	1.04e-04	187	177	6	4527d6426f2c4397e47f12439a13a8c14fd2aab2
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	TTC28 CETP SHANK3 PCDH15 FGD5 CA4	1.04e-04	187	177	6	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	STON1 NRCAM CPXM2 GPX8 SVEP1 BBOX1	1.04e-04	187	177	6	08c73d125e0638c9e9878165bba2442c266c8a48
ToppCell	COVID-19-kidney\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK3 HKDC1 GRB14 SIM1 AGBL4 BBOX1	1.04e-04	187	177	6	d23aae9419d460b78b1d4092d7acd9108a47cfbe
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	DOCK3 MYH7 OBSCN PARVB TENM2 XIRP2	1.04e-04	187	177	6	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPXM2 GRB14 SIM1 ITPR1 KCNJ1 FRMD3	1.07e-04	188	177	6	bc089cd73d283ed7d2ecbb3936673b4edc89f666
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPXM2 GRB14 SIM1 ITPR1 KCNJ1 FRMD3	1.07e-04	188	177	6	eec3d353e51358db4c7621265ee0fdd4298e5b0e
ToppCell	COVID-19-kidney-CD-PC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK3 NRCAM SIM1 AGBL4 KCNJ1 GAREM1	1.07e-04	188	177	6	8f9996c3f3b27efaaae8960a66af77412de9c7ef
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZCWPW1 KIF1A GRB14 TBC1D25 MYRFL CIAO3	1.07e-04	188	177	6	c2febf9fd4632af1f922067c3a30e5c50f75f480
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK3 CPXM2 GRB14 SIM1 ITPR1 KCNJ1	1.10e-04	189	177	6	f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MYH7 OBSCN LAMA2 PARVB TENM2 XIRP2	1.10e-04	189	177	6	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CPXM2 PKHD1L1 SHANK3 PCDH15 PRKCH FGD5	1.10e-04	189	177	6	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPXM2 GRB14 SIM1 ITPR1 KCNJ1 FRMD3	1.10e-04	189	177	6	977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCell	droplet-Mammary_Gland-nan-3m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBKBP1 PARVB SHANK3 PRKCH FGD5 CA4	1.10e-04	189	177	6	1d4ad307c0606957dd7bf8da84450e5193cf4a50
ToppCell	droplet-Mammary_Gland-nan-3m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBKBP1 PARVB SHANK3 PRKCH FGD5 CA4	1.10e-04	189	177	6	b952026044d5f6c0adce60cf24f6e0199e6f8757
ToppCell	facs-Heart-LA/RA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH7 ANK3 OBSCN XIRP2 MOV10L1 SBK2	1.10e-04	189	177	6	a08b2d0fa35ffa510050ecffdc68e1b79bbe1632
ToppCell	ASK428-Epithelial-Transformed_epithelium\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	CCDC71L STON1 ADAMTS1 GPX8 PKHD1L1 OSR1	1.10e-04	189	177	6	87189275234b5d59484c58acbb14a09903f2b578
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	PKHD1L1 SHANK3 ITPR1 PCDH15 PRKCH FGD5	1.10e-04	189	177	6	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PARVB SHANK3 USP31 FGD5 MERTK CA4	1.10e-04	189	177	6	e82211b9dc7540e7a183be2cbcfae39fdf503949
ToppCell	droplet-Mammary_Gland-nan-3m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBKBP1 PARVB SHANK3 PRKCH FGD5 CA4	1.10e-04	189	177	6	25781edbd08c6e413740b796ecc8ba1934bd3aa5
Drug	Azacitidine	MYH7 PCDHA9 ADAMTS1 PCDHA12 BCAT1 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 MOV10L1 CDK4	8.14e-07	415	175	15	ctd:D001374
Drug	Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A	KIF13B ATAD5 NAB1 LAMA2 PCDHA5 AP4E1 PLD2 TSC22D4 ANAPC5 GAREM1	3.25e-06	198	175	10	5837_UP
Disease	1,5 anhydroglucitol measurement	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1	7.33e-18	29	175	11	EFO_0008009
Disease	visceral adipose tissue measurement, body mass index	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 NBAS	1.56e-13	87	175	12	EFO_0004340, EFO_0004765
Disease	post-traumatic stress disorder symptom measurement	PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 KARS1 IFT52	6.15e-11	82	175	10	EFO_0008535
Disease	neutrophil count, basophil count	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PTPN22 PCDHA4 PCDHA3 PCDHA2 PCDHA1	1.08e-08	224	175	12	EFO_0004833, EFO_0005090
Disease	vital capacity	USP34 MICAL1 PCDHA9 STON1 KIF1A ADAMTS1 ATAD5 LAMA2 PCDHA13 HKDC1 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 APOB PCDHA1 TENM2 SVEP1 ITPR1 KCNJ1 ADAMTS15	8.64e-08	1236	175	25	EFO_0004312
Disease	Abnormality of refraction	DOCK3 ARHGAP32 PCDHA9 ANK3 LAMA2 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ADD3 TMEM106B	6.04e-07	673	175	17	HP_0000539
Disease	neuroticism measurement, cognitive function measurement	CACNA1E PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SIM1 TMEM106B SEMA3E	1.59e-06	566	175	15	EFO_0007660, EFO_0008354
Disease	4-acetamidobutanoate measurement	PANX2 MAPK12 MOV10L1 DENND6B	2.06e-06	16	175	4	EFO_0021003
Disease	post-traumatic stress disorder	PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TMEM106B	3.57e-06	202	175	9	EFO_0001358
Disease	neutrophil count	CCDC71L PCDHA9 ZNF266 TTC28 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PTPN22 PCDHA4 PCDHA3 PCDHA2 PCDHA1 NHLRC2 TENT5B AP4E1 BRCA1 ARVCF SULT6B1 TBC1D12 TNFAIP3	7.96e-06	1382	175	23	EFO_0004833
Disease	Malignant neoplasm of breast	MYH1 MICAL1 NRCAM NET1 ADAMTS1 OBSCN LAMA2 PANX2 SIM1 MAMDC4 ZNF546 BRCA1 BRCA2 KCNJ1 WDCP FGD5 PLD2 TSC22D4 ANAPC5	2.27e-05	1074	175	19	C0006142
Disease	pulse pressure measurement	CCDC71L USP34 AMPD3 PCDHA9 TTC28 NAB1 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SVEP1 ARVCF SULT6B1 TBC1D12 ADAMTS15 FGD5	2.80e-05	1392	175	22	EFO_0005763
Disease	ductal carcinoma in situ (biomarker_via_orthology)	BRCA1 BRCA2	3.50e-05	2	175	2	DOID:0060074 (biomarker_via_orthology)
Disease	Hereditary site-specific ovarian cancer syndrome	BRCA1 BRCA2	3.50e-05	2	175	2	C4749652
Disease	depressive symptom measurement	CACNA1E PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TENM2 TMEM106B BTN1A1 SEMA3E	5.16e-05	426	175	11	EFO_0007006
Disease	familial hemiplegic migraine 1 (implicated_via_orthology)	CACNA1B CACNA1E	1.05e-04	3	175	2	DOID:0111181 (implicated_via_orthology)
Disease	migraine (implicated_via_orthology)	CACNA1B CACNA1E	2.08e-04	4	175	2	DOID:6364 (implicated_via_orthology)
Disease	Hereditary breast ovarian cancer syndrome	BRCA1 BRCA2	2.08e-04	4	175	2	cv:C0677776
Disease	polymyositis	NAB1 PTPN22 TMEM106B	2.17e-04	20	175	3	EFO_0003063
Disease	autism spectrum disorder (implicated_via_orthology)	ARHGAP32 SLC9A9 NRCAM SHANK3 NDST3 ARVCF	3.03e-04	152	175	6	DOID:0060041 (implicated_via_orthology)
Disease	isoleucine measurement	TNPO1 LAMA2 GRB14 CFAP57	3.45e-04	56	175	4	EFO_0009793
Disease	hereditary breast ovarian cancer syndrome (is_implicated_in)	BRCA1 BRCA2	3.46e-04	5	175	2	DOID:5683 (is_implicated_in)
Disease	Hypoplastic Left Heart Syndrome	PCDHA9 PCDHA13	3.46e-04	5	175	2	C0152101
Disease	fibrinogen measurement	DCHS2 ZNF251 SHANK3 ITPR1 PCCB	4.92e-04	109	175	5	EFO_0004623
Disease	Adult only	BRCA1 BRCA2	5.16e-04	6	175	2	C3842001
Disease	Drug habituation	NRCAM TENM2 AGBL4 PCDH15 PRKCH	6.28e-04	115	175	5	C0013170
Disease	Drug abuse	NRCAM TENM2 AGBL4 PCDH15 PRKCH	6.28e-04	115	175	5	C0013146
Disease	Prescription Drug Abuse	NRCAM TENM2 AGBL4 PCDH15 PRKCH	6.28e-04	115	175	5	C4316881
Disease	Substance-Related Disorders	NRCAM TENM2 AGBL4 PCDH15 PRKCH	6.28e-04	115	175	5	C0236969
Disease	Drug Use Disorders	NRCAM TENM2 AGBL4 PCDH15 PRKCH	6.28e-04	115	175	5	C0013222
Disease	Drug Dependence	NRCAM TENM2 AGBL4 PCDH15 PRKCH	6.28e-04	115	175	5	C1510472
Disease	Substance Dependence	NRCAM TENM2 AGBL4 PCDH15 PRKCH	6.28e-04	115	175	5	C0038580
Disease	Substance Use Disorders	NRCAM TENM2 AGBL4 PCDH15 PRKCH	6.28e-04	115	175	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	NRCAM TENM2 AGBL4 PCDH15 PRKCH	6.28e-04	115	175	5	C0029231
Disease	Substance abuse problem	NRCAM TENM2 AGBL4 PCDH15 PRKCH	6.54e-04	116	175	5	C0740858
Disease	hereditary ataxia (implicated_via_orthology)	CACNA1B CACNA1E	7.20e-04	7	175	2	DOID:0050951 (implicated_via_orthology)
Disease	unipolar depression	CACNA1E MICAL1 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SIM1 TENM2 FAM135B USP31 AGBL4 TMEM106B NBAS BTN1A1 SEMA3E	8.73e-04	1206	175	17	EFO_0003761
Disease	marginal zone B-cell lymphoma	APOB PRKCH	9.57e-04	8	175	2	EFO_1000630
Disease	aspartate aminotransferase measurement	TNPO1 STON1 TTC28 CETP OBSCN HKDC1 PARVB NHLRC2 ITPR1 AGBL4 TMEM106B BRCA1 SH3TC1 MERTK	1.04e-03	904	175	14	EFO_0004736
Disease	IGA Glomerulonephritis	LAIR1 CD44 MERTK	1.07e-03	34	175	3	C0017661
Disease	non-high density lipoprotein cholesterol measurement	TNPO1 KIF13B USP34 ZNF266 CETP GRB14 APOB NHLRC2 SIM1 AGBL4 BRCA2 PCCB	1.18e-03	713	175	12	EFO_0005689
Disease	Global developmental delay	CACNA1B CACNA1E POLR2A NBAS KARS1	1.21e-03	133	175	5	C0557874
Disease	Pancreatic carcinoma, familial	BRCA1 BRCA2	1.23e-03	9	175	2	C2931038
Disease	systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus	NAB1 PTPN22 TNFAIP3	1.49e-03	38	175	3	EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH7	1.53e-03	10	175	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH7	1.53e-03	10	175	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH7	1.53e-03	10	175	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH7	1.53e-03	10	175	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH7	1.53e-03	10	175	2	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH7	1.53e-03	10	175	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH7	1.53e-03	10	175	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH7	1.53e-03	10	175	2	DOID:0080326 (implicated_via_orthology)
Disease	Fanconi anemia (is_implicated_in)	BRCA1 BRCA2	1.53e-03	10	175	2	DOID:13636 (is_implicated_in)
Disease	Calcium channel blocker use measurement	CCDC71L USP34 NHLRC2 SVEP1 ARVCF AKR1B1	1.76e-03	213	175	6	EFO_0009930
Disease	cholesteryl esters to total lipids in small HDL percentage	CETP APOB PCCB	2.13e-03	43	175	3	EFO_0022254
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH7	2.22e-03	12	175	2	DOID:11720 (implicated_via_orthology)
Disease	integral membrane protein 2B measurement	CETP APOB	2.22e-03	12	175	2	EFO_0802634
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH7	2.22e-03	12	175	2	DOID:2106 (implicated_via_orthology)
Disease	concentration of large LDL particles measurement	TBKBP1 CETP APOB	2.27e-03	44	175	3	EFO_0022160
Disease	cholesterol in medium VLDL measurement	TBKBP1 CETP APOB	2.27e-03	44	175	3	EFO_0022225
Disease	total lipids in very small VLDL measurement	CETP APOB PCCB	2.42e-03	45	175	3	EFO_0022156
Disease	hypertension	CCDC71L AMPD3 STON1 NHLRC2 FGD5 AKR1B1 FRMD3	2.46e-03	307	175	7	EFO_0000537
Disease	Alzheimer disease, gastroesophageal reflux disease	PCDHA4 PCDHA3 PCDHA2 PCDHA1 FAM135B TMEM106B	2.47e-03	228	175	6	EFO_0003948, MONDO_0004975
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH7	2.61e-03	13	175	2	DOID:397 (implicated_via_orthology)
Disease	Benign tumor of pancreas	BRCA1 BRCA2	2.61e-03	13	175	2	C0347284
Disease	FVC change measurement, response to placebo	KIF1A ORC5	2.61e-03	13	175	2	EFO_0008344, EFO_0010339
Disease	Hyperlipoproteinemia Type IIb	CETP APOB	2.61e-03	13	175	2	C1704417
Disease	free cholesterol in small VLDL measurement	TBKBP1 CETP APOB	2.75e-03	47	175	3	EFO_0022272
Disease	free cholesterol in very small VLDL measurement	CETP APOB PCCB	2.75e-03	47	175	3	EFO_0022275
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	CETP APOB SIM1 PCCB	2.90e-03	99	175	4	EFO_0004611, EFO_0007878
Disease	Hereditary Breast and Ovarian Cancer Syndrome	BRCA1 BRCA2	3.04e-03	14	175	2	C0677776
Disease	cholesterol in small LDL measurement	TBKBP1 CETP APOB	3.09e-03	49	175	3	EFO_0022227
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	CETP APOB SIM1 PCCB	3.23e-03	102	175	4	EFO_0004329, EFO_0004611
Disease	triglycerides to total lipids in medium LDL percentage	CETP APOB PCCB	3.28e-03	50	175	3	EFO_0022334
Disease	Tourette syndrome	OTUD1 TENM2 TMEM106B	3.28e-03	50	175	3	EFO_0004895
Disease	phospholipids in very small VLDL measurement	CETP APOB PCCB	3.47e-03	51	175	3	EFO_0022300
Disease	cholesterol to total lipids in small HDL percentage	CETP APOB PCCB	3.47e-03	51	175	3	EFO_0022240
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH7	3.49e-03	15	175	2	DOID:0050646 (implicated_via_orthology)
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	CETP APOB	3.49e-03	15	175	2	EFO_0022328
Disease	Hypertriglyceridemia	CETP APOB	3.49e-03	15	175	2	C0020557
Disease	N-acetylmethionine measurement	DOCK3 ITPR1	3.49e-03	15	175	2	EFO_0021427
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	TBKBP1 CETP APOB NHLRC2	3.84e-03	107	175	4	EFO_0004614, EFO_0004615
Disease	triglycerides in HDL measurement	CETP APOB PCCB	3.86e-03	53	175	3	EFO_0022317
Disease	free cholesterol to total lipids in small LDL percentage	CETP APOB PCCB	3.86e-03	53	175	3	EFO_0022286
Disease	Hyperlipoproteinemia Type IIa	CETP APOB	3.97e-03	16	175	2	C0745103
Disease	triglycerides in very large HDL measurement	CETP APOB PCCB	4.29e-03	55	175	3	EFO_0022324
Disease	triglyceride measurement, intermediate density lipoprotein measurement	CETP APOB BRCA2 PCCB	4.37e-03	111	175	4	EFO_0004530, EFO_0008595
Disease	thyroxine measurement, triiodothyronine measurement	STON1 MAPK12	4.49e-03	17	175	2	EFO_0005130, EFO_0008392
Disease	Lipidemias	CETP APOB	4.49e-03	17	175	2	C1706412
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	CETP APOB	4.49e-03	17	175	2	EFO_0022232
Disease	Hyperlipidemia	CETP APOB	4.49e-03	17	175	2	C0020473
Disease	ovarian cancer (is_implicated_in)	APOB BRCA1 BRCA2	4.51e-03	56	175	3	DOID:2394 (is_implicated_in)
Disease	triglycerides in very large VLDL measurement	CETP APOB PCCB	4.51e-03	56	175	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	CETP APOB PCCB	4.51e-03	56	175	3	EFO_0022333
Disease	cholesteryl esters to total lipids in medium HDL percentage	CETP APOB PCCB	4.51e-03	56	175	3	EFO_0022251
Disease	low density lipoprotein cholesterol measurement, lipid measurement	TBKBP1 CETP APOB BRCA2	4.81e-03	114	175	4	EFO_0004529, EFO_0004611
Disease	antihyperlipidemic drug use measurement	ZNF266 CETP APOB GAREM1	4.96e-03	115	175	4	EFO_0803367
Disease	triglycerides in IDL measurement	CETP APOB PCCB	4.98e-03	58	175	3	EFO_0022149
Disease	triacylglycerol 56:3 measurement	BCAT1 SYT16	5.03e-03	18	175	2	EFO_0010430
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	CETP APOB	5.03e-03	18	175	2	EFO_0008317, EFO_0008589

Protein segments in the cluster

Peptide	Gene	Start	Entry
FQKGGPYHDVLHSIL	TBC1D12	561	O60347
TDVLSFPFHEHLKAG	YBEY	61	P58557
PEHFYKGELKVLLHS	MAMDC4	1061	Q6UXC1
LHEGYKDLAALLHDG	APAF1	76	O14727
LHYFEGIHLDIPKET	ATAD5	1821	Q96QE3
PLFYSEKEAKAHHIG	AGBL3	241	Q8NEM8
EAVSYIERHKHGPFL	ARSD	281	P51689
DAPDCYLSFHKLLLH	CETP	156	P11597
GDPVITASYLESHHK	CETP	236	P11597
RNLSYHVHKEVPGAD	ARVCF	576	O00192
LHPGSSALHYAVELF	BCAT1	81	P54687
IDHSGVELHLAGTYK	CSMD2	3311	Q7Z408
FEYLTRDSSILGPHH	CACNA1E	1726	Q15878
TAHPHLFLYEDSKSV	BTN1A1	311	Q13410
EGYSLPHAVTKLHVA	ACTRT2	171	Q8TDY3
LKIDHTGFSPHAAIY	ADD3	206	Q9UEY8
SVALYKHFLSLPDGE	BCDIN3D	81	Q7Z5W3
IPPGIHFLHYSSVDK	AAR2	51	Q9Y312
IAAHLPDLIVYGHFS	ADCY10	16	Q96PN6
DTKPGLYTAYTAHLH	DENND6B	376	Q8NEG7
FEYLTRDSSILGPHH	CACNA1B	1711	Q00975
PHLYRDGHEEALSKF	ASPM	871	Q8IZT6
HGHLSSLIDISPYKF	PHYKPL	141	Q8IUZ5
VKFHGADLEHYLLTL	ADAMTS15	231	Q8TE58
LLSCTSHKDYPFHEE	AKR1B1	301	P15121
FLHKGLHVSLSTDDP	AMPD3	651	Q01432
GYLAVSLFLHESHEL	AP4E1	116	Q9UPM8
LKLYAVEISDHPGEH	CPXM2	351	Q8N436
GAFYATIIHDLGLHD	NDST3	251	O95803
LPLTHYELVTDAFGH	RBM15	541	Q96T37
HAESGKVYALQPLDH	PCDHA9	511	Q9Y5H5
AEFHGSGLKHYLLTL	ADAMTS1	271	Q9UHI8
KHHDSSALGVYSYIP	PTPN22	516	Q9Y2R2
GKPEAHFSLIHYAGI	MYH7	571	P12883
DHFVSHPGKYTLIEV	PARP3	141	Q9Y6F1
HAESGKVYALQPLDH	PCDHA2	511	Q9Y5H9
LHYSVPEEAKHGTFV	PCDHA6	31	Q9UN73
HAESGKVYALQPLDH	PCDHA6	511	Q9UN73
THIFGDLDSYIPLHE	NET1	216	Q7Z628
LEHSVKKAVHFGLPY	ANAPC5	361	Q9UJX4
HLPVKESHDYYSLGD	MEIOB	141	Q8N635
HAESGKVYALQPLDH	PCDHA7	511	Q9UN72
YIADHLDHFSPLIEG	OTUD1	346	Q5VV17
LHYSVPEEAKHGTFV	PCDHA8	31	Q9Y5H6
HTESGKVYALQPLDH	PCDHA8	511	Q9Y5H6
HAESGKVYALQPLDH	PCDHA3	511	Q9Y5H8
EYSPSKVHLIGHSLG	PNLIPRP3	156	Q17RR3
APVHEATHFYGTILL	MOV10L1	251	Q9BXT6
LEFVAKVHGSYPHSF	MAGEB16	291	A2A368
VEHYKKAPIFTSEHG	NCK2	356	O43639
GAKGSALHEDIYVLH	NRCAM	491	Q92823
ELLGAHHAITQFYPD	MERTK	136	Q12866
KHLATGHYLAAEVDP	ITPR1	306	Q14643
HSSESLGILKDYPHS	NAB1	456	Q13506
EEAYSISLHPSGHFI	CFAP57	431	Q96MR6
ELKYSHLFIGTDHLP	CFAP65	1256	Q6ZU64
EHAPASQGLKAEHLY	LAIR1	151	Q6GTX8
PKKFAGLASYLHGHE	DDX60L	1416	Q5H9U9
VKALAEYFHILDVHG	EFCAB9	26	A8MZ26
HKIDFVAHDDIPYSS	PCYT1B	161	Q9Y5K3
ITYSLHGPGAHEFKL	FAT2	3046	Q9NYQ8
GSSEVGPIFHLYHKK	FGD5	1421	Q6ZNL6
AHSLEEGHYVIGPKI	GAREM1	66	Q9H706
HSLLNSHYEKLPDVG	MYRFL	226	Q96LU7
DPLGLIAYLSHFHSA	MICAL1	596	Q8TDZ2
SFYSKIHPLENGEIH	LAMA2	201	P24043
PEAHFSLIHYAGTVD	MYH1	576	P12882
GSGQLHYSIPEEAKH	PCDHA5	26	Q9Y5H7
HYSIPEEAKHGTFVG	PCDHA5	31	Q9Y5H7
YLGASVDKLHHPLEF	ARHGAP32	1216	A7KAX9
LHLFETLKTDPEAFH	NBAS	1726	A2RRP1
VHYKEHLSLPLVDEG	DMPK	291	Q09013
LLPDLHALEHTYSDK	NHLRC2	96	Q8NBF2
YHSSLVVDHPALAFL	LRRC8B	471	Q6P9F7
DHLPNLYGFSALHAV	OSR1	36	Q8TAX0
PLHHFYLTPESFDQK	PARVB	301	Q9HBI1
HGMSYDHDLFLIDPL	DCHS2	2816	Q6V1P9
LHYSIPEEAKHGTFV	PCDHA1	31	Q9Y5I3
HAESGKVYALQPLDH	PCDHA1	511	Q9Y5I3
LHYSVPEEAKHGTFV	PCDHA13	31	Q9Y5I0
HAESGKVYALQPLDH	PCDHA13	511	Q9Y5I0
TDPEAAKYVHGIAVH	GBA	336	P04062
PLYNDSFHEISHKGR	OBSCN	2596	Q5VST9
KDPHLHTPIYLFLGS	OR5AC1	51	P0C628
HGAKLLYAFAEATVP	PCCB	411	P05166
HAESGKVYALQPLDH	PCDHA4	511	Q9UN74
VKHFFALHPFTGELS	PCDH15	861	Q96QU1
TEGFKYPLGHEVNHS	BRCA1	826	P38398
EDVRLFLDSKHPGHY	GAK	436	O14976
LLKAHTLETYGVDPH	FRMD3	211	A2A2Y4
LHFKSVGFHLPSREF	APOB	1321	P04114
EDHDGLVFVKPSHLY	CERS3	26	Q8IU89
HKYFHPKEALVSSGV	IFT52	121	Q9Y366
LPYKGSEHSLDGEHF	CA4	121	P22748
PNLSVAEKGHYSLHF	DOCK3	1826	Q8IZD9
APGQEFLSKSHLYEH	BRCA2	2351	P51587
LLEGYTSHYPHTKES	CD44	556	P16070
YKARDPHSGHFVALK	CDK4	21	P11802
KTDESGPHSHRLYYL	DPP9	61	Q86TI2
VLHFSSGQIEKHYPD	CENPJ	1226	Q9HC77
TGKLSFHTDYPALHH	BBOX1	196	O75936
DPKTSLEFYIDIHAH	AGBL4	316	Q5VU57
ESKSGFTPLHIAAHY	ANK3	231	Q12955
KSGLTPLHVAAHYDN	ANK3	596	Q12955
KYHIDLDPHFNDILG	CSNK2A2	261	P19784
SSTYPEIHGFLHAKE	GRB14	231	Q14449
HQFSPHILRSKDVYG	CCDC71L	86	Q8N9Z2
YLNKLHTFLSLSGPH	FAM135B	1236	Q49AJ0
YLGLKELHKEFGPSH	GPX8	86	Q8TED1
ELHKEFGPSHFSVLA	GPX8	91	Q8TED1
FDTVPGHLTEDLHLY	RUBCN	836	Q92622
HSYSFLTEPVLHGDL	SBK2	131	P0C263
KLTAFEHHEIFSYPE	DYRK2	166	Q92630
VSKKGYLHFLEPHTS	KIF1A	1576	Q12756
RHFSLDVHPYILGTK	PANX2	511	Q96RD6
HAESGKVYALQPLDH	PCDHA12	511	Q9UN75
ILAHAFFPKTHREGD	MMP11	176	P24347
HLSEGALAIEVYGHK	KIF13B	941	Q9NQT8
SHLPLHSSKEDAYDG	TMEM106B	6	Q9NUM4
ATHLHYDKLPGSIFE	SULT6B1	116	Q6IMI4
ASGYLHIGHAKAALL	EPRS1	206	P07814
EYVASLHLPTFDAHL	AHCYL2	571	Q96HN2
KPPLSDAEFHTYLNH	TBC1D25	196	Q3MII6
SFDHKYLKPILTHSG	SLC9A9	531	Q8IVB4
EKLFYLSHLHPEGEM	SYT16	451	Q17RD7
ALYFTHDASLVHKSP	TSC22D4	266	Q9Y3Q8
GEDPYPHKFHVDISL	KARS1	91	Q15046
KYSHLQPGDHLTDIT	KARS1	111	Q15046
TVGVDGTLYKLHPHF	HKDC1	856	Q2TB90
LKGLSAHTHVELPYY	ORC5	291	O43913
HPHGVFYEKDSEGSL	HEPH	126	Q9BQS7
VFHSPDITGLLEHYK	SOCS4	351	Q8WXH5
LILAKDYLHSDISPH	SIM1	671	P81133
SPDLLPTNYHVFKHL	SETMAR	616	Q53H47
GHGELAEHFYLKALS	SH3TC1	1206	Q8TE82
FHGGLYDPLTKLVHF	TENM2	2411	Q9NT68
PFHILIALETYKTGH	RO60	321	P10155
STPKEEHCYLLHSFE	SVEP1	236	Q4LDE5
LEKLGYSRDVHPAFS	SPATC1L	261	Q9H0A9
ASHVLHPESGLGYKD	TENT5B	111	Q96A09
TFLHLHGKTFDYKIP	SSRP1	221	Q08945
YAEKTHGSFILPHIS	CIAO3	196	Q9H6Q4
GHHETLEDDAPYILK	CHST10	281	O43529
FKHAPPTYEDVIAGH	XIRP2	3276	A4UGR9
LFHLHERTHTGEKPY	ZNF823	206	P16415
FKHILVDGDTLSYHG	SPRYD3	46	Q8NCJ5
LFTSHLDSLPSKYHV	ZCWPW1	346	Q9H0M4
LAEHFRSHTGEKPYE	ZNF334	336	Q9HCZ1
SQLGHLEHVYSGEKP	ZNF19	426	P17023
GHIYPTVDREHFKSA	RPA4	246	Q13156
GYDSHHFVPLVTLKD	TNFAIP3	251	P21580
DHPHCLSYKLELGSD	STON1	646	Q9Y6Q2
HTSFADGHTFLLEKP	SHANK3	1396	Q9BYB0
GLEKSPYCHLLDSSH	RMND5B	246	Q96G75
NKLDLYHEHSFTELP	TLR9	531	Q9NR96
GFKHRTLPHFIKDDY	POLR2A	801	P24928
PHHEDLVAIGYKDGI	GEMIN5	161	Q8TEQ6
LTQHFRLHTGEKPYS	ZNF546	736	Q86UE3
YSHLPELHIFQIKGE	ZNF808	161	Q8N4W9
GELDLHGIPHSIYKT	PKHD1L1	3156	Q86WI1
LADSVGHHLNKPEYI	TNPO1	556	Q92973
GLSAHLVIHTGEKPY	ZNF480	441	Q8WV37
KYQLGSSFHSHLPEL	ZNF888	136	P0CJ79
LAPGAGIVKFHEHYL	TTC28	1251	Q96AY4
SLFLHHRVHTGEKPY	ZNF251	391	Q9BRH9
LKHPSASHILGFFLF	VN1R5	156	Q7Z5H4
DLTAHFLIHSGEKPY	ZNF528	451	Q3MIS6
VKYQLGFSFHSHLPE	ZNF765	136	Q7L2R6
YSHLPELHIFQIKGE	ZNF611	161	Q8N823
HAGPITKHGEIDYEA	PSMC6	316	P62333
DVDYLHHKYPGTSIV	SLC29A4	91	Q7RTT9
RVGYHLEDPLFHLES	SEMA3E	146	O15041
HLKFGLDYHRLSSPT	USP31	421	Q70CQ4
GVKPHSKHLTEYFAF	USP34	2431	Q70CQ2
SSSYLEPLDLTHIHF	WDCP	276	Q9H6R7
YSHLVSVGHLVGKPD	ZNF674	41	Q2M3X9
GYPDDALIKHIDSHL	TBKBP1	596	A7MCY6
GHLVHFPLKFLEDES	PLD2	901	O14939
LFIHKALHTGEKPYE	ZNF468	286	Q5VIY5
YKHTHEGDPLESVVF	TWF2	241	Q6IBS0
FLEHVRTHTGEKPYG	ZNF560	391	Q96MR9
FLSEHQRTHIGEKPY	ZNF527	316	Q8NB42
VHDITFDPDTAHKYL	TRIM16L	156	Q309B1
SFQLHERTHTGEKPY	ZNF266	506	Q14584
AVAYIHKDLPEFHPS	KCNJ1	101	P48048
TAGEALAHPYFESLH	MAPK12	301	P53778
HLELAVFHETPLGYD	PRKCH	81	P24723
LLHSKYGLHVSPAYE	NECTIN4	81	Q96NY8